BWAY

Brainsway Ltd

Add to Watchlist

Advanced Chart

12.100

+0.01(0.083%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

12.9499

Open

12.030

VWAP

11.94

Vol

21.46K

Mkt Cap

457.32M

Low

11.8371

Amount

256.31K

EV/EBITDA(TTM)

44.02

Total Shares

16.66M

163.86M

EV/OCF(TTM)

13.51

P/S(TTM)

5.64

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

12.34M

+23.29%

12.82M

+22.09%

13.48M

+18.08%

Estimates Revision

The market is revising Upward the revenue expectations for BrainsWay Ltd. (BWAY) for FY2025, with the revenue forecasts being adjusted by 0.58% over the past three months. During the same period, the stock price has changed by 37.66%.

Revenue Estimates for FY2025

Revise Upward

+0.58%

In Past 3 Month

Stock Price

Go Up

+37.66%

In Past 3 Month

3 Analyst Rating

26.69% Upside

Wall Street analysts forecast BWAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BWAY is 15.33 USD with a low forecast of 15.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

26.69% Upside

Current: 12.100

Low

15.00

Averages

15.33

High

16.00

26.69% Upside

Current: 12.100

Low

15.00

Averages

15.33

High

16.00

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

$16

2025-03-12

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

$16

2025-03-12

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

$16

2024-12-23

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

$16

2024-12-23

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

$16

2024-10-21

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

$16

2024-10-21

Reiterates

Strong Buy

Reason

Northland Capital Markets

Carl Byrnes

Buy

Maintains

$11 → $13

2024-10-03

Reason

Northland Capital Markets

Carl Byrnes

Price Target

$11 → $13

2024-10-03

Maintains

Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

$16

2024-09-16

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

$16

2024-09-16

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Maintains

$15 → $16

2024-08-08

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

$15 → $16

2024-08-08

Maintains

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Brainsway Ltd (BWAY.O) is 87.93, compared to its 5-year average forward P/E of 30.75. For a more detailed relative valuation and DCF analysis to assess Brainsway Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

30.75

Current PE

87.93

Overvalued PE

118.86

Undervalued PE

-57.36

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-5.61

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

5.37

Undervalued EV/EBITDA

-16.58

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Overvalued

5Y Average PS

3.06

Current PS

4.38

Overvalued PS

4.36

Undervalued PS

1.75

Financials

Annual

Quarterly

FY2025Q1

YoY :

+26.84%

11.54M

Total Revenue

FY2025Q1

YoY :

+519.35%

576.00K

Operating Profit

FY2025Q1

YoY :

+897.30%

1.11M

Net Income after Tax

FY2025Q1

0.02

EPS - Diluted

FY2025Q1

YoY :

+61.65%

3.97M

Free Cash Flow

FY2025Q1

YoY :

-0.35%

74.64

Gross Profit Margin - %

FY2025Q1

YoY :

+29.20%

18.45

FCF Margin - %

FY2025Q1

YoY :

+686.89%

9.60

Net Margin - %

FY2025Q1

7.13

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

BWAY News & Events

Events Timeline

2025-06-11 (ET)

2025-06-11

07:33:37

Brainsway announces preliminary results from Accelerated Deep TMS study

2025-06-04 (ET)

2025-06-04

07:31:49

Brainsway announces $5M minority-stake investment in Stella MSO

2025-05-13 (ET)

2025-05-13

07:38:34

Brainsway sees FY25 revenue $49M-$51M, consensus $49.82M

News

4.0

06-12Benzinga

HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $16 Price Target

9.0

06-11Newsfilter

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

1.0

06-10Newsfilter

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

People Also Watch

America's CAR-MART Inc

Allogene Therapeutics Inc

Berry Corporation (Bry)

First Business Financial Services Inc

Eton Pharmaceuticals Inc

American Public Education Inc

Revance Therapeutics Inc

Gilat Satellite Networks Ltd

8.100

USD

+2.14%

FAQ

What is Brainsway Ltd (BWAY) stock price today?

The current price of BWAY is 12.1 USD — it has increased 0.08 % in the last trading day.

BWAY

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

BWAY News & Events

Events Timeline

News

People Also Watch

FAQ

What is Brainsway Ltd (BWAY) stock price today?

What is Brainsway Ltd (BWAY)'s business?

What is the price predicton of BWAY Stock?

What is Brainsway Ltd (BWAY)'s revenue for the last quarter?

What is Brainsway Ltd (BWAY)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Brainsway Ltd (BWAY)'s fundamentals?

How many employees does Brainsway Ltd (BWAY). have?

What is Brainsway Ltd (BWAY) market cap?